Clinical Network Services (CNS) Press Room

Press Release: 3 January 2017
pdfCNS_Announces_Appointment_of_Martin_Moxham.pdf (pdf, 55kB)

News Update: 26 March 2016
As acting local sponsor & CRO, CNS oversaw the first patient in the ANZ region dosed in Auckland for Novavax’s history making trial to protect infants via maternal immunization. The study aims to prevent Respiratory Syncytial Virus (RSV) infection in infants via immunization of third-trimester pregnant women and is the first study to use an investigational product in pregnant participants.

Press Release: 6 January 2016
pdfCNS expands its BioDesk service into Washington D.C. (pdf, 241kB)

News Update: 29 October 2015:
As local applicants, CNS was proud to be involved in the first GMO approval for clinical trials in New Zealand 

Press Release: 26 August 2015
pdfMedidata's Cloud-Based Platform Powers Next-Generation Immunotherapy Vaccine Trial in Australia (pdf, 82kB)

News Update: 12 August 2015 
Clinical Network Services (UK) Ltd granted a - Qualification of an enterprise as a micro, small or medium-sized enterprise (SME) for EMA related services.

Article: July 2015
Perspectives from CROs on the Australian clinical trial environment
By Gabrielle McKee, COO & Executive Director, Clinical Network Services (CNS) Pty Ltd: 
pdfTrends in Clinical Trials in Australia (pdf, 124kB)
Featured in Australasian Bio Technology July edition

Press Release: 9 June 2015
pdfClinical Network Services (CNS) voted Australia's Favourite CRO 2015 (pdf, 135kB)

Press Release: 8 January 2015
pdfClinical Network Services (CNS) establishes US operations (pdf, 148kB)

Press Release: 3 November 2014
pdfDr Richard Turner joins the UK team and UK office granted SME status by the EMA (pdf, 152kB)

Press Release: 22 September 2014
pdfCNS and Ventac Partners sign cooperative partnership (pdf, 309kB)

Press Release: 22 April 2014
pdfCNS contracted by Nuvilex Inc for clinical regulatory support (pdf, 99kB)

Press Release: 10 March 2014
pdfCNS opens new UK office and expands Core Services (pdf, 146kB)

Press Release: 20 January 2014
pdfCNS participates in Panel at 13th Annual Phacilitate Vaccine Forum (pdf, 59kB)

Press Release: 4 March 2013
pdfCNS appoints Douglas Francis (pdf, 179kB)

Press Release: 7 January 2013
pdfCNS acquires Beltas Assets (pdf, 51 kB)

Press Release: 1 December 2011
pdfBioDesk Launch (pdf, 129 kB)